Article by Micah Blumberg, Journalist & Software Engineer
Facebook Horizon combines the massive multiplayer online world building such as seen in games like Minecraft & Roblox, with visual game scripting seen in the popular VR app Rec Room, and the online social chat experiences of apps like AltSpace & VR Chat. All in one.
I felt that Paige was the perfect person to learn about Facebook Horizon from because she has been an early pre-alpha tester creating some of the very first Horizon worlds that you will be able to explore when Horizon launches later this month.
Here is a link to the video…
The 28 day average daily death rate from April 06 to May 04 is 2076. If the death rate increases by 2000 a day, which is between a low daily death increase rate of 1,500 and a high daily death increase rate of 2,500, then we may hit 100,000 deaths in the United States by May 20th.
If the next 2 weeks are like the past 28 days then we ought to cross the 100,000 death count in the USA by May 20th, 2020.
Interestingly my predictions are now in alignment with the new IHME COVID-19 projections. Although I derived my projections independently. …
A news & analysis of the research and therapeutics around the Covid-19 disease and the Sars-CoV-2 virus’s impact on human biology written up by Micah Blumberg, Neurohacker, Journalist, and WebXR A-Frame Software Architect at Silicon Valley Global News http://svgn.io http://vrma.io
First thing to know is that when someone is infected with Sars-Cov-2 there are two main receptor paths for it to attack your cells ACE2 and CD147.
Blood cells and the endothelium have the ACE2 receptor, and T-cells (your immune cells) have the CD147-spike protein.
“Angiotensin-converting enzyme 2 (ACE2) is an enzyme attached to the outer surface (cell membranes) of cells in the lungs, arteries, heart, kidney, and intestines. ACE2 lowers blood pressure by catalysing the hydrolysis of angiotensin II (a vasoconstrictor peptide) into angiotensin (1–7) (a vasodilator). ACE2 counters the activity of the related angiotensin-converting enzyme (ACE) by reducing the amount of angiotensin-II and increasing Ang(1–7) making it a promising drug target for treating cardiovascular diseases. …